Wellness Institute for Sleep & Health
No triage bot, no call center — a real physician reads your intake. Async telemedicine, no video call, licensed in Washington, Oregon, and Montana.
*Promotional first-order rate. Standard pricing $179/order from month 2.
Board-Certified Physician Review
Licensed 503A Compounding Pharmacy
No Video Call Required
No Charge Unless Approved
Semaglutide is a GLP-1 receptor agonist that reduces appetite by mimicking the GLP-1 hormone, signaling fullness and slowing gastric emptying. Originally approved for type 2 diabetes (Ozempic) and later for chronic weight management (Wegovy), semaglutide has become one of the most widely studied medications in obesity medicine. In clinical trials (STEP 1), patients on semaglutide lost an average of approximately 15% of body weight over 68 weeks with diet and lifestyle support. WISH uses compounded semaglutide prepared by Hallandale, a licensed 503A compounding pharmacy, under physician oversight, prescribed for dose flexibility — so titration and refill adjustments are guided by how you’re responding rather than a fixed schedule. It’s also typically more affordable than the brand-name product.
Looking for tirzepatide? Compare both programs →
Semaglutide mimics the GLP-1 hormone to reduce appetite and slow gastric emptying. It acts on brain receptors that regulate hunger and fullness signals, leading to reduced caloric intake over time.
Semaglutide is self-administered once weekly via subcutaneous injection. Most patients find the injection quick and straightforward after the first time. Every order includes a complete injection kit. Full injection & storage guide →
In the STEP 1 clinical trial, patients on semaglutide 2.4 mg/week lost an average of 14.9% of body weight over 68 weeks compared to 2.4% with placebo. Individual results vary based on adherence and health status.
Fill out a secure online intake form covering your health history, goals, and eligibility. Takes about 10–15 minutes. No video call or in-person visit required.
A board-certified WISH physician reviews your intake within 1–3 business days. You will receive an email with the outcome — approval or a note if further information is needed.
If approved, your saved card is charged and a prescription is sent directly to our 503A pharmacy. If not approved, your card is never charged — no refund needed.
Your medication ships via temperature-controlled cold-chain courier and arrives within 2 business days of processing. Tracking info sent by email.
Your physician selects your starting dose based on your health history. Most new patients begin at Level 1 and progress gradually based on tolerability and results. Each order is a 4-week (monthly) supply.
All pricing is for a 4-week (1-month) supply. Injection supplies and cold-chain shipping are included in the price shown — every order, every month, no itemized add-ons.
Semaglutide pricing across telehealth programs typically comes wrapped in membership fees or separate medication charges that make the real monthly cost hard to pin down. WISH’s semaglutide program is $149 for your first order and $179 for every order after that – all-inclusive, with no separate membership fee. Here’s how that compares to other programs we’ve researched.
*Pricing reflects rates published by comparable local and national GLP-1 telehealth providers as of September 2026, and may change over time.
You likely qualify if…
Are 18 years or older
Live in Washington, Oregon, or Montana
BMI 30 or higher, OR BMI 27–29.9 with a weight-related condition (type 2 diabetes, hypertension, sleep apnea, PCOS, high cholesterol, or joint pain)
No personal or first-degree family history of medullary thyroid carcinoma or MEN2
This program is not for you if…
Currently pregnant, trying to conceive, or breastfeeding
Personal or first-degree family history of medullary thyroid carcinoma or MEN2
History of severe pancreatitis
Known allergy to semaglutide or a GLP-1 agonist medication
Current or past diagnosis of anorexia nervosa or a restrictive eating disorder
Reside outside Washington, Oregon, or Montana
If you’re currently taking semaglutide (Ozempic, Wegovy, or compounded) through another provider and want to transfer your prescription to WISH, you can continue at your current dose level — no need to restart from the beginning. Your intake form asks about your current dose so we can match your prescription. As a transfer patient, you get 10% off standard pricing automatically at Levels 2–5 — no code needed.
If you’re considering switching from semaglutide to tirzepatide (which has a dual GIP/GLP-1 mechanism), see our tirzepatide program page for information and pricing. A new patient intake is required for the new medication.
Dr. Patel is a board-certified physician trained across metabolic health, sleep medicine, and internal medicine — and every intake gets his personal review, not a rubber stamp. WISH patients get real physician oversight without the in-person visit or the waiting room.
Compounded semaglutide contains the same active ingredient (semaglutide) as the branded medications but is not the same FDA-approved product. It is prepared by a licensed 503A pharmacy under physician oversight. Compounded medications are not FDA-approved. It’s prescribed for dose flexibility, so your physician can adjust between refills based on your response rather than a fixed dosing schedule — and it’s typically less expensive than the brand-name version.
No. WISH uses asynchronous (store-and-forward) telemedicine, which means our physician reviews your intake form without a real-time appointment. This is authorized under Washington, Oregon, and Montana telehealth law.
Most patients notice appetite reduction within the first few weeks of starting. Meaningful weight loss typically becomes apparent by months 2–3. Clinical trials showed average weight loss of approximately 15% over 68 weeks. Individual results vary based on adherence, diet, starting weight, and health status.
If our physician determines the program isn’t appropriate for you, your card is never charged. You may receive a recommendation to schedule a telehealth consultation instead. We review every intake individually.
Both are GLP-1-based medications for weight management. Tirzepatide activates both GIP and GLP-1 receptors (dual agonist), while semaglutide activates GLP-1 only. Clinical trials show tirzepatide typically produces greater average weight loss (15–21% vs. ~15%). Semaglutide is available at a lower starting price ($149 vs. $199). Individual response varies and your physician can help guide your selection. View tirzepatide program →
No. WISH Weight Management is a cash-pay telemedicine program. We do not bill insurance and do not provide superbills. The pricing shown is all-in: medication, physician review, shipping, and supplies.
Washington, Oregon, and Montana. WISH physicians are licensed in all three states. We are not currently able to prescribe in other states.
Contact us at [email protected]. There is no subscription — each order requires a separate approval. You may pause or stop at any time. Weight regain after discontinuing GLP-1 medications is common; your physician can discuss a tapering plan if relevant.
For most patients, long-term. Obesity is generally treated as a chronic condition rather than a course of treatment with a fixed end date, and the STEP trials followed patients for well over a year with sustained benefit. Some patients move to a lower maintenance dose once they reach their goal; others stay at their effective dose indefinitely. Your physician revisits this with you at each refill.
Complete your intake in about 10–15 minutes. A WISH physician will review your health information within 1–3 business days — no video call, no waiting room.
Questions? [email protected] · Physician review within 1–3 business days.